{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T06:49:57Z","timestamp":1793861397665,"version":"4.6.1"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,11,9]],"date-time":"2015-11-09T00:00:00Z","timestamp":1447027200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Immunogenetics"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1007\/s00251-015-0880-z","type":"journal-article","created":{"date-parts":[[2015,11,9]],"date-time":"2015-11-09T09:13:51Z","timestamp":1447060431000},"page":"29-41","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":74,"title":["The diversity of the HLA-E-restricted peptide repertoire explains the immunological impact of the Arg107Gly mismatch"],"prefix":"10.1007","volume":"68","author":[{"given":"Alexander A.","family":"Celik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Kraemer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trevor","family":"Huyton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rainer","family":"Blasczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Bade-D\u00f6ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,11,9]]},"reference":[{"key":"880_CR1","doi-asserted-by":"crossref","first-page":"110","DOI":"10.3324\/haematol.2010.030924","volume":"96","author":"C Bade-Doding","year":"2011","unstructured":"Bade-Doding C, Theodossis A, Gras S, Kjer-Nielsen L, Eiz-Vesper B, Seltsam A, Huyton T, Rossjohn J, McCluskey J, Blasczyk R (2011) The impact of human leukocyte antigen (HLA) micropolymorphism on ligand specificity within the HLA-B*41 allotypic family. Haematologica 96:110\u2013118. doi: 10.3324\/haematol.2010.030924","journal-title":"Haematologica"},{"key":"880_CR2","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s00251-004-0677-y","volume":"56","author":"C Bade-Doeding","year":"2004","unstructured":"Bade-Doeding C, Elsner HA, Eiz-Vesper B, Seltsam A, Holtkamp U, Blasczyk R (2004) A single amino-acid polymorphism in pocket A of HLA-A*6602 alters the auxiliary anchors compared with HLA-A*6601 ligands. Immunogenetics 56:83\u201388. doi: 10.1007\/s00251-004-0677-y","journal-title":"Immunogenetics"},{"key":"880_CR3","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s00251-007-0197-7","volume":"59","author":"C Bade-Doeding","year":"2007","unstructured":"Bade-Doeding C, DeLuca DS, Seltsam A, Blasczyk R, Eiz-Vesper B (2007) Amino acid 95 causes strong alteration of peptide position Pomega in HLA-B*41 variants. Immunogenetics 59:253\u2013259. doi: 10.1007\/s00251-007-0197-7","journal-title":"Immunogenetics"},{"key":"880_CR4","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s00251-011-0583-z","volume":"64","author":"S Badrinath","year":"2012","unstructured":"Badrinath S, Huyton T, Schumacher H, Blasczyk R, Bade-Doeding C (2012a) Position 45 influences the peptide binding motif of HLA-B*44:08. Immunogenetics 64:245\u2013249. doi: 10.1007\/s00251-011-0583-z","journal-title":"Immunogenetics"},{"key":"880_CR5","doi-asserted-by":"crossref","first-page":"98","DOI":"10.3324\/haematol.2011.046037","volume":"97","author":"S Badrinath","year":"2012","unstructured":"Badrinath S, Saunders P, Huyton T, Aufderbeck S, Hiller O, Blasczyk R, Bade-Doeding C (2012b) Position 156 influences the peptide repertoire and tapasin dependency of human leukocyte antigen B*44 allotypes. Haematologica 97:98\u2013106. doi: 10.3324\/haematol.2011.046037","journal-title":"Haematologica"},{"key":"880_CR6","first-page":"9","volume":"4","author":"S Badrinath","year":"2014","unstructured":"Badrinath S, Huyton T, Kunze-Schumacher H, Elsner HA, Blasczyk R, Bade-Doeding C (2014) Differential impact of HLA-B*44 allelic mismatches at position 156 on peptide binding specificities and T-cell diversity. Stem Cell Res Ther 4:9. doi: 10.4172\/2157-7633.1000192","journal-title":"Stem Cell Res. Ther."},{"key":"880_CR7","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1146\/annurev.bi.59.070190.001345","volume":"59","author":"PJ Bjorkman","year":"1990","unstructured":"Bjorkman PJ, Parham P (1990) Structure, function, and diversity of class I major histocompatibility complex molecules. Annu Rev Biochem 59:253\u2013288. doi: 10.1146\/annurev.bi.59.070190.001345","journal-title":"Annu Rev Biochem"},{"key":"880_CR8","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1002\/eji.1830270517","volume":"27","author":"V Braud","year":"1997","unstructured":"Braud V, Jones EY, McMichael A (1997) The human major histocompatibility complex class Ib molecule HLA-E binds signal sequence-derived peptides with primary anchor residues at positions 2 and 9. Eur J Immunol 27:1164\u20131169. doi: 10.1002\/eji.1830270517","journal-title":"Eur J Immunol"},{"key":"880_CR9","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1038\/35869","volume":"391","author":"VM Braud","year":"1998","unstructured":"Braud VM, Allan DS, O\u2019Callaghan CA, Soderstrom K, D\u2019Andrea A, Ogg GS, Lazetic S, Young NT, Bell JI, Phillips JH, Lanier LL, McMichael AJ (1998) HLA-E binds to natural killer cell receptors CD94\/NKG2A, B and C. Nature 391:795\u2013799. doi: 10.1038\/35869","journal-title":"Nature"},{"key":"880_CR10","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1084\/jem.185.4.795","volume":"185","author":"AG Brooks","year":"1997","unstructured":"Brooks AG, Posch PE, Scorzelli CJ, Borrego F, Coligan JE (1997) NKG2A complexed with CD94 defines a novel inhibitory natural killer cell receptor. J Exp Med 185:795\u2013800","journal-title":"J Exp Med"},{"key":"880_CR11","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.it.2005.11.001","volume":"27","author":"SR Burrows","year":"2006","unstructured":"Burrows SR, Rossjohn J, McCluskey J (2006) Have we cut ourselves too short in mapping CTL epitopes? Trends Immunol 27:11\u201316. doi: 10.1016\/j.it.2005.11.001","journal-title":"Trends Immunol"},{"key":"880_CR12","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1182\/blood-2008-07-171926","volume":"113","author":"S Cooley","year":"2009","unstructured":"Cooley S, Trachtenberg E, Bergemann TL, Saeteurn K, Klein J, Le CT, Marsh SG, Guethlein LA, Parham P, Miller JS, Weisdorf DJ (2009) Donors with group B KIR haplotypes improve relapse-free survival after unrelated hematopoietic cell transplantation for acute myelogenous leukemia. Blood 113:726\u2013732. doi: 10.1182\/blood-2008-07-171926","journal-title":"Blood"},{"key":"880_CR13","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1097\/TP.0b013e3181b0e79e","volume":"88","author":"M Danzer","year":"2009","unstructured":"Danzer M, Polin H, Proll J, Haunschmid R, Hofer K, Stabentheiner S, Hackl C, Kasparu H, Konig J, Hauser H, Binder M, Weiss R, Gabriel C, Krieger O (2009) Clinical significance of HLA-E*0103 homozygosity on survival after allogeneic hematopoietic stem-cell transplantation. Transplantation 88:528\u2013532. doi: 10.1097\/TP.0b013e3181b0e79e","journal-title":"Transplantation"},{"key":"880_CR14","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1038\/sj.leu.2401778","volume":"14","author":"HG Drexler","year":"2000","unstructured":"Drexler HG, Matsuo Y (2000) Malignant hematopoietic cell lines: in vitro models for the study of natural killer cell leukemia-lymphoma. Leukemia 14:777\u2013782","journal-title":"Leukemia"},{"key":"880_CR15","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/j.1399-0039.2010.01547.x","volume":"76","author":"NE Elamin","year":"2010","unstructured":"Elamin NE, Bade-Doeding C, Blasczyk R, Eiz-Vesper B (2010) Polymorphism between HLA-A*0301 and A*0302 located outside the pocket F alters the Pomega peptide motif. Tissue Antigens 76:487\u2013490. doi: 10.1111\/j.1399-0039.2010.01547.x","journal-title":"Tissue Antigens"},{"key":"880_CR16","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/tan.12283","volume":"83","author":"LP Felicio","year":"2014","unstructured":"Felicio LP, Porto IO, Mendes-Junior CT, Veiga-Castelli LC, Santos KE, Vianello-Brondani RP, Sabbagh A, Moreau P, Donadi EA, Castelli EC (2014) Worldwide HLA-E nucleotide and haplotype variability reveals a conserved gene for coding and 3\u2032 untranslated regions. Tissue Antigens 83:82\u201393. doi: 10.1111\/tan.12283","journal-title":"Tissue Antigens"},{"key":"880_CR17","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0198-8859(96)00241-8","volume":"52","author":"C Grimsley","year":"1997","unstructured":"Grimsley C, Ober C (1997) Population genetic studies of HLA-E: evidence for selection. Hum Immunol 52:33\u201340. doi: 10.1016\/S0198-8859(96)00241-8","journal-title":"Hum Immunol"},{"key":"880_CR18","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1097\/QAD.0b013e32835f5b9c","volume":"27","author":"M Guzman-Fulgencio","year":"2013","unstructured":"Guzman-Fulgencio M, Berenguer J, Rallon N, Fernandez-Rodriguez A, Miralles P, Soriano V, Jimenez-Sousa MA, Cosin J, Medrano J, Garcia-Alvarez M, Lopez JC, Benito JM, Resino S (2013) HLA-E variants are associated with sustained virological response in HIV\/hepatitis C virus-coinfected patients on hepatitis C virus therapy. AIDS 27:1231\u20131238. doi: 10.1097\/QAD.0b013e32835f5b9c","journal-title":"AIDS"},{"key":"880_CR19","first-page":"161","volume":"9","author":"M Hirosawa","year":"1993","unstructured":"Hirosawa M, Hoshida M, Ishikawa M, Toya T (1993) MASCOT: multiple alignment system for protein sequences based on three-way dynamic programming. Comput Appl Biosci: CABIOS 9:161\u2013167","journal-title":"Comput. Appl. Biosci.: CABIOS"},{"key":"880_CR20","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/ni1312","volume":"7","author":"HL Hoare","year":"2006","unstructured":"Hoare HL, Sullivan LC, Pietra G, Clements CS, Lee EJ, Ely LK, Beddoe T, Falco M, Kjer-Nielsen L, Reid HH, McCluskey J, Moretta L, Rossjohn J, Brooks AG (2006) Structural basis for a major histocompatibility complex class Ib-restricted T cell response. Nat Immunol 7:256\u2013264. doi: 10.1038\/ni1312","journal-title":"Nat Immunol"},{"key":"880_CR21","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.leukres.2013.01.011","volume":"37","author":"E Hosseini","year":"2013","unstructured":"Hosseini E, Schwarer AP, Jalali A, Ghasemzadeh M (2013) The impact of HLA-E polymorphisms on relapse following allogeneic hematopoietic stem cell transplantation. Leuk Res 37:516\u2013519. doi: 10.1016\/j.leukres.2013.01.011","journal-title":"Leuk Res"},{"key":"880_CR22","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/s00251-012-0625-1","volume":"64","author":"T Huyton","year":"2012","unstructured":"Huyton T, Schumacher H, Blasczyk R, Bade-Doeding C (2012) Residue 81 confers a restricted C-terminal peptide binding motif in HLA-B*44:09. Immunogenetics 64:663\u2013668. doi: 10.1007\/s00251-012-0625-1","journal-title":"Immunogenetics"},{"key":"880_CR23","doi-asserted-by":"crossref","first-page":"2878","DOI":"10.4049\/jimmunol.174.5.2878","volume":"174","author":"BK Kaiser","year":"2005","unstructured":"Kaiser BK, Barahmand-Pour F, Paulsene W, Medley S, Geraghty DE, Strong RK (2005) Interactions between NKG2x immunoreceptors and HLA-E ligands display overlapping affinities and thermodynamics. J Immunol 174:2878\u20132884","journal-title":"J Immunol"},{"key":"880_CR24","doi-asserted-by":"crossref","first-page":"352160","DOI":"10.1155\/2014\/352160","volume":"2014","author":"T Kraemer","year":"2014","unstructured":"Kraemer T, Blasczyk R, Bade-Doeding C (2014) HLA-E: a novel player for histocompatibility. J Immunol Res 2014:352160. doi: 10.1155\/2014\/352160","journal-title":"J. Immunol. Res."},{"key":"880_CR25","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1155\/2015\/346714","volume":"2015","author":"T Kraemer","year":"2015","unstructured":"Kraemer T, Celik AA, Huyton T, Kunze-Schumacher H, Blasczyk R, Bade-D\u00f6ding C (2015) HLA-E: presentation of a broader peptide repertoire impacts the cellular immune response-implications on HSCT outcome. Stem Cells Int 2015:12. doi: 10.1155\/2015\/346714","journal-title":"Stem Cells Int."},{"key":"880_CR26","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1038\/leu.2011.138","volume":"25","author":"N Kroger","year":"2011","unstructured":"Kroger N, Zabelina T, Berger J, Duske H, Klyuchnikov E, Binder T, Stubig T, Hilde-brandt Y, Atanackovic D, Alchalby H, Ayuk F, Zander AR, Bacher U, Eiermann T (2011) Donor KIR haplotype B improves progression-free and overall survival after allogeneic hematopoietic stem cell transplantation for multiple myeloma. Leukemia 25:1657\u20131661. doi: 10.1038\/leu.2011.138","journal-title":"Leukemia"},{"key":"880_CR27","doi-asserted-by":"crossref","first-page":"246171","DOI":"10.1155\/2014\/246171","volume":"2014","author":"H Kunze-Schumacher","year":"2014","unstructured":"Kunze-Schumacher H, Blasczyk R, Bade-Doeding C (2014) Soluble HLA technology as a strategy to evaluate the impact of HLA mismatches. J Immunol Res 2014:246171. doi: 10.1155\/2014\/246171","journal-title":"J. Immunol. Res."},{"key":"880_CR28","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1086\/498877","volume":"193","author":"J Lajoie","year":"2006","unstructured":"Lajoie J, Hargrove J, Zijenah LS, Humphrey JH, Ward BJ, Roger M (2006) Genetic variants in nonclassical major histocompatibility complex class I human leukocyte antigen (HLA)-E and HLA-G molecules are associated with susceptibility to heterosexual acquisition of HIV-1. J Infect Dis 193:298\u2013301. doi: 10.1086\/498877","journal-title":"J Infect Dis"},{"key":"880_CR29","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.molimm.2012.07.009","volume":"53","author":"MH Lampen","year":"2013","unstructured":"Lampen MH, Hassan C, Sluijter M, Geluk A, Dijkman K, Tjon JM, de Ru AH, van der Burg SH, van Veelen PA, van Hall T (2013) Alternative peptide repertoire of HLA-E reveals a binding motif that is strikingly similar to HLA-A2. Mol Immunol 53:126\u2013131. doi: 10.1016\/j.molimm.2012.07.009","journal-title":"Mol Immunol"},{"key":"880_CR30","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/ni1581","volume":"9","author":"LL Lanier","year":"2008","unstructured":"Lanier LL (2008) Up on the tightrope: natural killer cell activation and inhibition. Nat Immunol 9:495\u2013502. doi: 10.1038\/ni1581","journal-title":"Nat Immunol"},{"key":"880_CR31","doi-asserted-by":"crossref","first-page":"4951","DOI":"10.4049\/jimmunol.160.10.4951","volume":"160","author":"N Lee","year":"1998","unstructured":"Lee N, Goodlett DR, Ishitani A, Marquardt H, Geraghty DE (1998a) HLA-E surface expression depends on binding of TAP-dependent peptides derived from certain HLA class I signal sequences. J Immunol 160:4951\u20134960","journal-title":"J Immunol"},{"key":"880_CR32","doi-asserted-by":"crossref","first-page":"5199","DOI":"10.1073\/pnas.95.9.5199","volume":"95","author":"N Lee","year":"1998","unstructured":"Lee N, Llano M, Carretero M, Ishitani A, Navarro F, Lopez-Botet M, Geraghty DE (1998b) HLA-E is a major ligand for the natural killer inhibitory receptor CD94\/NKG2A. Proc Natl Acad Sci U S A 95:5199\u20135204","journal-title":"Proc Natl Acad Sci U S A"},{"key":"880_CR33","doi-asserted-by":"crossref","first-page":"2854","DOI":"10.1002\/(SICI)1521-4141(199809)28:09<2854::AID-IMMU2854>3.0.CO;2-W","volume":"28","author":"M Llano","year":"1998","unstructured":"Llano M, Lee N, Navarro F, Garcia P, Albar JP, Geraghty DE, Lopez-Botet M (1998) HLA-E-bound peptides influence recognition by inhibitory and triggering CD94\/NKG2 receptors: preferential response to an HLA-G-derived nonamer. Eur J Immunol 28:2854\u20132863. doi: 10.1002\/(SICI)1521-4141(199809)28:09<2854::AID-IMMU2854>3.0.CO;2-W","journal-title":"Eur J Immunol"},{"key":"880_CR34","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1084\/jem.20030066","volume":"198","author":"WA Macdonald","year":"2003","unstructured":"Macdonald WA, Purcell AW, Mifsud NA, Ely LK, Williams DS, Chang L, Gorman JJ, Clements CS, Kjer-Nielsen L, Koelle DM, Burrows SR, Tait BD, Holdsworth R, Brooks AG, Lovrecz GO, Lu L, Rossjohn J, McCluskey J (2003) A naturally selected dimorphism within the HLA-B44 supertype alters class I structure, peptide repertoire, and T cell recognition. J Exp Med 198:679\u2013691. doi: 10.1084\/jem.20030066","journal-title":"J Exp Med"},{"key":"880_CR35","doi-asserted-by":"crossref","first-page":"3240","DOI":"10.1002\/eji.200535343","volume":"35","author":"P Mazzarino","year":"2005","unstructured":"Mazzarino P, Pietra G, Vacca P, Falco M, Colau D, Coulie P, Moretta L, Mingari MC (2005) Identification of effector-memory CMV-specific T lymphocytes that kill CMV-infected target cells in an HLA-E-restricted fashion. Eur J Immunol 35:3240\u20133247. doi: 10.1002\/eji.200535343","journal-title":"Eur J Immunol"},{"key":"880_CR36","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/S0952-7915(00)00242-9","volume":"13","author":"CW McMahon","year":"2001","unstructured":"McMahon CW, Raulet DH (2001) Expression and function of NK cell receptors in CD8+ T cells. Curr Opin Immunol 13:465\u2013470","journal-title":"Curr Opin Immunol"},{"key":"880_CR37","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1084\/jem.20020797","volume":"196","author":"J Michaelsson","year":"2002","unstructured":"Michaelsson J, Teixeira de Matos C, Achour A, Lanier LL, Karre K, Soderstrom K (2002) A signal peptide derived from hsp60 binds HLA-E and interferes with CD94\/NKG2A recognition. J Exp Med 196:1403\u20131414","journal-title":"J Exp Med"},{"key":"880_CR38","doi-asserted-by":"crossref","first-page":"12433","DOI":"10.1073\/pnas.93.22.12433","volume":"93","author":"MC Mingari","year":"1996","unstructured":"Mingari MC, Schiavetti F, Ponte M, Vitale C, Maggi E, Romagnani S, Demarest J, Pantaleo G, Fauci AS, Moretta L (1996) Human CD8+ T lymphocyte subsets that express HLA class I-specific inhibitory receptors represent oligoclonally or monoclonally expanded cell populations. Proc Natl Acad Sci U S A 93:12433\u201312438","journal-title":"Proc Natl Acad Sci U S A"},{"key":"880_CR39","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S0002-9440(10)62267-5","volume":"166","author":"J Nattermann","year":"2005","unstructured":"Nattermann J, Nischalke HD, Hofmeister V, Ahlenstiel G, Zimmermann H, Leifeld L, Weiss EH, Sauerbruch T, Spengler U (2005a) The HLA-A2 restricted T cell epitope HCV core 35\u201344 stabilizes HLA-E expression and inhibits cytolysis mediated by natural killer cells. Am J Pathol 166:443\u2013453. doi: 10.1016\/S0002-9440(10)62267-5","journal-title":"Am J Pathol"},{"key":"880_CR40","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1177\/135965350501000107","volume":"10","author":"J Nattermann","year":"2005","unstructured":"Nattermann J, Nischalke HD, Hofmeister V, Kupfer B, Ahlenstiel G, Feldmann G, Rockstroh J, Weiss EH, Sauerbruch T, Spengler U (2005b) HIV-1 infection leads to increased HLA-E expression resulting in impaired function of natural killer cells. Antivir Ther 10:95\u2013107","journal-title":"Antivir Ther"},{"key":"880_CR41","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1136\/gut.2005.076463","volume":"55","author":"J Nattermann","year":"2006","unstructured":"Nattermann J, Feldmann G, Ahlenstiel G, Langhans B, Sauerbruch T, Spengler U (2006) Surface expression and cytolytic function of natural killer cell receptors is altered in chronic hepatitis C. Gut 55:869\u2013877. doi: 10.1136\/gut.2005.076463","journal-title":"Gut"},{"key":"880_CR42","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1084\/jem.20091429","volume":"207","author":"CC Oliveira","year":"2010","unstructured":"Oliveira CC, van Veelen PA, Querido B, de Ru A, Sluijter M, Laban S, Drijfhout JW, van der Burg SH, Offringa R, van Hall T (2010) The nonpolymorphic MHC Qa-1b mediates CD8+ T cell surveillance of antigen-processing defects. J Exp Med 207:207\u2013221. doi: 10.1084\/jem.20091429","journal-title":"J Exp Med"},{"key":"880_CR43","doi-asserted-by":"crossref","first-page":"4005","DOI":"10.1073\/pnas.85.11.4005","volume":"85","author":"P Parham","year":"1988","unstructured":"Parham P, Lomen CE, Lawlor DA, Ways JP, Holmes N, Coppin HL, Salter RD, Wan AM, Ennis PD (1988) Nature of polymorphism in HLA-A, -B, and -C molecules. Proc Natl Acad Sci U S A 85:4005\u20134009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"880_CR44","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S1074-7613(03)00355-8","volume":"20","author":"B Park","year":"2004","unstructured":"Park B, Kim Y, Shin J, Lee S, Cho K, Fruh K, Lee S, Ahn K (2004) Human cytomegalovirus inhibits tapasin-dependent peptide loading and optimization of the MHC class I peptide cargo for immune evasion. Immunity 20:71\u201385","journal-title":"Immunity"},{"key":"880_CR45","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1084\/jem.20072525","volume":"205","author":"EJ Petrie","year":"2008","unstructured":"Petrie EJ, Clements CS, Lin J, Sullivan LC, Johnson D, Huyton T, Heroux A, Hoare HL, Beddoe T, Reid HH, Wilce MC, Brooks AG, Rossjohn J (2008) CD94-NKG2A recognition of human leukocyte antigen (HLA)-E bound to an HLA class I leader sequence. J Exp Med 205:725\u2013735. doi: 10.1084\/jem.20072525","journal-title":"J Exp Med"},{"key":"880_CR46","doi-asserted-by":"crossref","first-page":"10896","DOI":"10.1073\/pnas.1834449100","volume":"100","author":"G Pietra","year":"2003","unstructured":"Pietra G, Romagnani C, Mazzarino P, Falco M, Millo E, Moretta A, Moretta L, Mingari MC (2003) HLA-E-restricted recognition of cytomegalovirus-derived peptides by human CD8+ cytolytic T lymphocytes. Proc Natl Acad Sci U S A 100:10896\u201310901. doi: 10.1073\/pnas.1834449100","journal-title":"Proc Natl Acad Sci U S A"},{"key":"880_CR47","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1146\/annurev.iy.11.040193.001241","volume":"11","author":"HG Rammensee","year":"1993","unstructured":"Rammensee HG, Falk K, Rotzschke O (1993) Peptides naturally presented by MHC class I molecules. Annu Rev Immunol 11:213\u2013244. doi: 10.1146\/annurev.iy.11.040193.001241","journal-title":"Annu Rev Immunol"},{"key":"880_CR48","doi-asserted-by":"crossref","first-page":"6829","DOI":"10.4049\/jimmunol.174.11.6829","volume":"174","author":"ME Ressing","year":"2005","unstructured":"Ressing ME, Keating SE, van Leeuwen D, Koppers-Lalic D, Pappworth IY, Wiertz EJ, Rowe M (2005) Impaired transporter associated with antigen processing-dependent peptide transport during productive EBV infection. J Immunol 174:6829\u20136838","journal-title":"J Immunol"},{"key":"880_CR49","first-page":"406","volume":"24","author":"MJ Robertson","year":"1996","unstructured":"Robertson MJ, Cochran KJ, Cameron C, Le JM, Tantravahi R, Ritz J (1996) Characterization of a cell line, NKL, derived from an aggressive human natural killer cell leukemia. Exp Hematol 24:406\u2013415","journal-title":"Exp Hematol"},{"key":"880_CR50","doi-asserted-by":"crossref","first-page":"D423","DOI":"10.1093\/nar\/gku1161","volume":"43","author":"J Robinson","year":"2015","unstructured":"Robinson J, Halliwell JA, Hayhurst JD, Flicek P, Parham P, Marsh SG (2015) The IPD and IMGT\/HLA database: allele variant databases. Nucleic Acids Res 43:D423\u2013D431. doi: 10.1093\/nar\/gku1161","journal-title":"Nucleic Acids Res"},{"key":"880_CR51","doi-asserted-by":"crossref","first-page":"11328","DOI":"10.1073\/pnas.172369799","volume":"99","author":"C Romagnani","year":"2002","unstructured":"Romagnani C, Pietra G, Falco M, Millo E, Mazzarino P, Biassoni R, Moretta A, Moretta L, Mingari MC (2002) Identification of HLA-E-specific alloreactive T lymphocytes: a cell subset that undergoes preferential expansion in mixed lymphocyte culture and displays a broad cytolytic activity against allogeneic cells. Proc Natl Acad Sci U S A 99:11328\u201311333. doi: 10.1073\/pnas.172369799","journal-title":"Proc Natl Acad Sci U S A"},{"key":"880_CR52","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1126\/science.1068440","volume":"295","author":"L Ruggeri","year":"2002","unstructured":"Ruggeri L, Capanni M, Urbani E, Perruccio K, Shlomchik WD, Tosti A, Posati S, Rogaia D, Frassoni F, Aversa F, Martelli MF, Velardi A (2002) Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants. Science 295:2097\u20132100. doi: 10.1126\/science.1068440","journal-title":"Science"},{"key":"880_CR53","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1086\/605889","volume":"200","author":"D Schulte","year":"2009","unstructured":"Schulte D, Vogel M, Langhans B, Kramer B, Korner C, Nischalke HD, Steinberg V, Michalk M, Berg T, Rockstroh JK, Sauerbruch T, Spengler U, Nattermann J (2009) The HLA-E(R)\/HLA-E(R) genotype affects the natural course of hepatitis C virus (HCV) infection and is associated with HLA-E-restricted recognition of an HCV-derived peptide by interferon-gamma-secreting human CD8(+) T cells. J Infect Dis 200:1397\u20131401. doi: 10.1086\/605889","journal-title":"J Infect Dis"},{"key":"880_CR54","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/(SICI)1521-4141(199801)28:01<122::AID-IMMU122>3.0.CO;2-F","volume":"28","author":"B Seliger","year":"1998","unstructured":"Seliger B, Harders C, Lohmann S, Momburg F, Urlinger S, Tampe R, Huber C (1998) Down-regulation of the MHC class I antigen-processing machinery after oncogenic transformation of murine fibroblasts. Eur J Immunol 28:122\u2013133. doi: 10.1002\/(SICI)1521-4141(199801)28:01<122::AID-IMMU122>3.0.CO;2-F","journal-title":"Eur J Immunol"},{"key":"880_CR55","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S0167-5699(00)01692-3","volume":"21","author":"B Seliger","year":"2000","unstructured":"Seliger B, Maeurer MJ, Ferrone S (2000) Antigen-processing machinery breakdown and tumor growth. Immunol Today 21:455\u2013464","journal-title":"Immunol Today"},{"key":"880_CR56","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.1399-0039.1994.tb02394.x","volume":"44","author":"A Steinle","year":"1994","unstructured":"Steinle A, Schendel DJ (1994) HLA class I alleles of LCL 721 and 174 \u00d7 CEM. T2(T2). Tissue Antigens 44:268\u2013270","journal-title":"Tissue Antigens"},{"key":"880_CR57","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1471-2172-2-5","volume":"2","author":"J Stevens","year":"2001","unstructured":"Stevens J, Joly E, Trowsdale J, Butcher GW (2001) Peptide binding characteristics of the non-classical class Ib MHC molecule HLA-E assessed by a recombinant random peptide approach. BMC Immunol 2:5","journal-title":"BMC Immunol"},{"key":"880_CR58","doi-asserted-by":"crossref","first-page":"5082","DOI":"10.1074\/jbc.M208268200","volume":"278","author":"RK Strong","year":"2003","unstructured":"Strong RK, Holmes MA, Li P, Braun L, Lee N, Geraghty DE (2003) HLA-E allelic variants. Correlating differential expression, peptide affinities, crystal structures, and thermal stabilities. J Biol Chem 278:5082\u20135090. doi: 10.1074\/jbc.M208268200","journal-title":"J Biol Chem"},{"key":"880_CR59","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1097\/01.tp.0000244598.92049.dd","volume":"82","author":"R Tamouza","year":"2006","unstructured":"Tamouza R, Busson M, Rocha V, Fortier C, Haddad Y, Brun M, Boukouaci W, Bleux H, Socie G, Krishnamoorthy R, Toubert A, Gluckman E, Charron D (2006) Homozygous status for HLA-E*0103 confers protection from acute graft-versus-host disease and transplant-related mortality in HLA-matched sibling hematopoietic stem cell transplantation. Transplantation 82:1436\u20131440. doi: 10.1097\/01.tp.0000244598.92049.dd","journal-title":"Transplantation"},{"key":"880_CR60","doi-asserted-by":"crossref","first-page":"372","DOI":"10.4049\/jimmunol.179.1.372","volume":"179","author":"G Terrazzano","year":"2007","unstructured":"Terrazzano G, Sica M, Gianfrani C, Mazzarella G, Maurano F, De Giulio B, de Saint-Mezard S, Zanzi D, Maiuri L, Londei M, Jabri B, Troncone R, Auricchio S, Zappacosta S, Carbone E (2007) Gliadin regulates the NK-dendritic cell cross-talk by HLA-E surface stabilization. J Immunol 179:372\u2013381","journal-title":"J Immunol"},{"key":"880_CR61","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1126\/science.287.5455.1031","volume":"287","author":"P Tomasec","year":"2000","unstructured":"Tomasec P, Braud VM, Rickards C, Powell MB, McSharry BP, Gadola S, Cerundolo V, Borysiewicz LK, McMichael AJ, Wilkinson GW (2000) Surface expression of HLA-E, an inhibitor of natural killer cells, enhanced by human cytomegalovirus gpUL40. Science 287:1031","journal-title":"Science"},{"key":"880_CR62","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1006\/clim.2001.5094","volume":"101","author":"A Vambutas","year":"2001","unstructured":"Vambutas A, DeVoti J, Pinn W, Steinberg BM, Bonagura VR (2001) Interaction of human papillomavirus type 11 E7 protein with TAP-1 results in the reduction of ATP-dependent peptide transport. Clin Immunol 101:94\u201399. doi: 10.1006\/clim.2001.5094","journal-title":"Clin Immunol"},{"key":"880_CR63","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1182\/asheducation-2013.1.335","volume":"2013","author":"MR Verneris","year":"2013","unstructured":"Verneris MR (2013) Natural killer cells and regulatory T cells: how to manipulate a graft for optimal GVL. Hematology Am Soc Hematol Educ Program 2013:335\u2013341. doi: 10.1182\/asheducation-2013.1.335","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"880_CR64","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1038\/384432a0","volume":"384","author":"EJ Wiertz","year":"1996","unstructured":"Wiertz EJ, Tortorella D, Bogyo M, Yu J, Mothes W, Jones TR, Rapoport TA, Ploegh HL (1996) Sec61-mediated transfer of a membrane protein from the endoplasmic reticulum to the proteasome for destruction. Nature 384:432\u2013438. doi: 10.1038\/384432a0","journal-title":"Nature"},{"key":"880_CR65","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.4049\/jimmunol.175.3.1383","volume":"175","author":"SL Wooden","year":"2005","unstructured":"Wooden SL, Kalb SR, Cotter RJ, Soloski MJ (2005) Cutting edge: HLA-E binds a peptide derived from the ATP-binding cassette transporter multidrug resistance-associated protein 7 and inhibits NK cell-mediated lysis. J Immunol 175:1383\u20131387","journal-title":"J Immunol"}],"container-title":["Immunogenetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00251-015-0880-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00251-015-0880-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00251-015-0880-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,15]],"date-time":"2023-08-15T19:59:28Z","timestamp":1692129568000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00251-015-0880-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11,9]]},"references-count":65,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,1]]}},"alternative-id":["880"],"URL":"https:\/\/doi.org\/10.1007\/s00251-015-0880-z","relation":{},"ISSN":["0093-7711","1432-1211"],"issn-type":[{"value":"0093-7711","type":"print"},{"value":"1432-1211","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11,9]]}}}